Showing results (661-670 of 695) with videos related to

Sort By:
Pageof 70
Bioorganic & Medicinal Chemistry Letters|November 27, 2010
Synthesis and SAR of novel CXCR4 antagonists that are potent inhibitors of T tropic (X4) HIV-1 replicationRenato Skerlj, Gary Bridger, Ernie McEachern, et al.
JCI Insight|February 5, 2026
Endothelial oncogenic KRAS mutation drives the dynamics of microglia and macrophages in brain arteriovenous malformationHyejin Park, Jung-Eun Park, Bridger H Freeman, et al.
Paediatrics & Child Health|April 17, 2026
Management of serious <i>Staphylococcus aureus</i> infections in children: A survey of paediatric infectious diseases physicians in CanadaAlison A Lopez, Nancy Nashid, Michelle Barton, et al.
Journal of Bacteriology|March 4, 2006
Transcriptional and biochemical analysis of starch metabolism in the hyperthermophilic archaeon Pyrococcus furiosusHan-Seung Lee, Keith R Shockley, Gerrit J Schut, et al.
Biochemical Pharmacology|June 23, 2009
Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4Veronique Bodart, Virginia Anastassov, Marilyn C Darkes, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Mitigating hERG Inhibition: Design of Orally Bioavailable CCR5 Antagonists as Potent Inhibitors of R5 HIV-1 ReplicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
American Journal of Human Genetics|December 1, 1999
Linkage of inflammatory bowel disease to human chromosome 6pJ Hampe, S H Shaw, R Saiz, et al.
Bioorganic & Medicinal Chemistry Letters|October 29, 2011
Design and synthesis of pyridin-2-ylmethylaminopiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
Pageof 70